Endocan as a prognostic biomarker of triple-negative breast cancer

PURPOSE: Triple-negative breast cancer (TNBC) has aggressive characteristics and fewer treatment options than other subtypes. The purpose of this study was to explore prognostic biomarkers for TNBC that can be easily detected from the blood samples. METHODS: MDA-MB-231 and MDA-MB-231BR, a brain meta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res Treat
Autors principals: Sagara, Atsunobu, Igarashi, Katsuhide, Otsuka, Maky, Kodama, Akihiro, Yamashita, Mutsumi, Sugiura, Rei, Karasawa, Takeshi, Arakawa, Kazuhiko, Narita, Michiko, Kuzumaki, Naoko, Narita, Minoru, Kato, Yoshinori
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2016
Matèries:
Preclinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225208/
https://ncbi.nlm.nih.gov/pubmed/27888420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4057-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars